We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.07B
1-Year Est. Return 78.71%
This Fund
S&P 500
This Quarter Est. Return
+14.23%
1 Year Est. Return
+78.71%
3 Year Est. Return
+323.31%
5 Year Est. Return
+574.14%
10 Year Est. Return
+3,824.29%
AUM
$2.8B
AUM Growth
+$635M
Cap. Flow
+$218M
Cap. Flow %
7.79%
Top 10 Hldgs %
49.77%
Holding
313
New
122
Increased
18
Reduced
66
Closed
70

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$183M
2
ESGR
Enstar Group
ESGR
+$157M
3
BPMC
Blueprint Medicines
BPMC
+$138M
4
SKX
Skechers
SKX
+$137M
5
DNB
Dun & Bradstreet
DNB
+$129M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$208M
2
PDCO
Patterson Companies, Inc.
PDCO
+$149M
3
ATSG
Air Transport Services Group
ATSG
+$95M
4
PLYA
Playa Hotels & Resorts
PLYA
+$93.6M
5
SWI
SolarWinds Corporation Common Stock
SWI
+$90.9M

Sector Composition

Rank Sector Weight
1 Financials 32.71%
2 Miscellaneous 18.12%
3 Healthcare 14.93%
4 Consumer Discretionary 10.35%
5 Industrials 7.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BACCU
76
Blue Acquisition Corp Unit
BACCU
$5.04M 0.18%
+502,000
New +$5.05M
CCAQ
77
Collective Acquisition Corp
CCAQ
$213M
$5.02M 0.18%
+499,937
New +$5.02M
CCCXU
78
DELISTED
Churchill Capital Corp X Unit
CCCXU
$4.89M 0.18%
+474,900
New +$4.93M
PELI
79
DELISTED
Pelican Acquisition Corp
PELI
$4.84M 0.17%
+482,628
New +$4.82M
ALDF
80
Aldel Financial II Inc
ALDF
$323M
$4.76M 0.17%
453,582
-259,627
-36% -$2.68M
WENNU
81
Wen Acquisition Corp Unit
WENNU
$4.7M 0.17%
+444,776
New +$4.72M
DTSQ
82
DT Cloud Star Acquisition Corp
DTSQ
$41.5M
$4.49M 0.16%
432,450
-1,007
-0.2% -$10.4K
ALF
83
Centurion Acquisition Corp
ALF
$391M
$4.45M 0.16%
422,891
-105,787
-20% -$1.1M
AMED
84
DELISTED
Amedisys
AMED
$4.39M 0.16%
+44,669
New +$4.23M
TDAC
85
Translational Development Acquisition Corp
TDAC
$210M
$4.32M 0.15%
421,008
+344
+0.1% +$3.5K
CHPG
86
ChampionsGate Acquisition Corp
CHPG
$104M
$4.25M 0.15%
+425,000
New +$4.25M
PMTR
87
Perimeter Acquisition Corp I
PMTR
$322M
$4.23M 0.15%
+416,328
New +$4.22M
SAGE
88
DELISTED
Sage Therapeutics
SAGE
$4.02M 0.14%
+441,108
New +$3.24M
OACC
89
Oaktree Acquisition Corp III Life Sciences
OACC
$265M
$3.81M 0.14%
365,100
-22,497
-6% -$233K
GSRT
90
DELISTED
GSR III Acquisition Corp
GSRT
$3.78M 0.14%
350,100
-428,261
-55% -$4.47M
TAVI
91
Tavia Acquisition Corp
TAVI
$171M
$3.59M 0.13%
350,001
-1
-0% -$10
RDAC
92
Rising Dragon Acquisition Corp
RDAC
$34.9M
$3.58M 0.13%
347,214
-229
-0.1% -$2.35K
LOKV
93
DELISTED
Live Oak Acquisition Corp V
LOKV
$3.48M 0.12%
+325,100
New +$3.35M
GNTY
94
DELISTED
Guaranty Bancshares
GNTY
$3.34M 0.12%
+78,750
New +$3.19M
CVAC
95
DELISTED
CureVac
CVAC
$3.23M 0.12%
+594,845
New +$2.36M
GENVR
96
Gen Digital Inc Contingent Value Rights
GENVR
$3.18M 0.11%
+396,507
New +$2.79M
NPAC
97
New Providence Acquisition Corp III
NPAC
$403M
$3.14M 0.11%
+307,755
New +$3.18M
FSHP
98
Flag Ship Acquisition Corp
FSHP
$40M
$3.05M 0.11%
293,297
-3,291
-1% -$34.2K
CAEP
99
DELISTED
Cantor Equity Partners III
CAEP
$3.05M 0.11%
+288,754
New +$3.04M
WTGUU
100
Wintergreen Acquisition Corp Unit
WTGUU
$3.03M 0.11%
+300,143
New +$3.02M
2 3
4
5 6

Similar funds

PI
PGGM Investments Zeist, Netherlands $4.06B AUM 24.91% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
AA
Advisory Alpha Holland, Michigan $4.08B AUM 20.62% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.57% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return

Glazer Capital LLC's Q2 2025 Portfolio in Review

As of Q2 2025, Glazer Capital LLC held 313 positions worth $2.8B, up 29% from $2.16B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Glazer Capital LLC deployed $218M of net new capital in Q2 2025, opening 122 new positions and adding to 18 existing holdings. Its largest new stake was SpringWorks Therapeutics: 4,107,199 shares worth $193M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Kellanova, an estimated $78.8M trimmed.

  • Glazer Capital LLC's largest Q2 2025 buy was SpringWorks Therapeutics: 4,107,199 shares worth $193M.
  • Glazer Capital LLC added most to Enstar Group in Q2 2025, an estimated $157M increase.
  • Glazer Capital LLC's biggest Q2 2025 reduction was Kellanova, cutting an estimated $78.8M.
  • Glazer Capital LLC fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $208M.
  • Glazer Capital LLC's ten largest holdings make up 50% of its $2.8B portfolio in Q2 2025.
  • Glazer Capital LLC opened 122 new positions and closed 70 in Q2 2025.
  • Glazer Capital LLC's portfolio value rose 29% quarter-over-quarter to $2.8B.

Based on Glazer Capital LLC's 13F filing for Q2 2025, filed 14 Aug 2025.